CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome
In the first part of the podcast, Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. In the second segment, Dr. Pearce Korb discusses the long-term outcomes of osmotic demyelination syndrome in an updated cohort with Dr. Whitney Fitts.
You May Also Like
Mindset Reset | Daily Motivation
Motivation
Self-Love Affirmations for Women
Motivation
You Are Heroic with Brian Johnson
Brian Johnson
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
The Human Upgrade: Biohacking for Longevity & Performance
Dave Asprey
Good Thinking: Positive Affirmations
Just Curious Media
Brian's Run Pod
Brian Patterson
Lifestyle of Longevity
Dr. Kati Ernst & Kristine Zeller
BlackBox - Verstehen, was im Kopf passiert
Psychologinnen Maxi Diers und Barbara Focke
HerbRally
Mason Hutchison
Mindset Reset | Daily Motivation
Motivation
Self-Love Affirmations for Women
Motivation
You Are Heroic with Brian Johnson
Brian Johnson
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
The Human Upgrade: Biohacking for Longevity & Performance
Dave Asprey
Good Thinking: Positive Affirmations
Just Curious Media
Brian's Run Pod
Brian Patterson
Lifestyle of Longevity
Dr. Kati Ernst & Kristine Zeller
BlackBox - Verstehen, was im Kopf passiert
Psychologinnen Maxi Diers und Barbara Focke
HerbRally
Mason Hutchison
Community discussion